Curio Digital Therapeutics: Pivotal Trial for Postpartum Depression Digital Therapeutic Meets Efficacy Endpoints
Digital Health Global
OCTOBER 6, 2023
Patients treated with MamaLift Plus demonstrated clinically meaningful, statistically significant improvements in depressive symptoms, as measured by the Edinburgh Postnatal Depression Scale PRINCETON, N.J.–(BUSINESS The SuMMER trial met its primary endpoint, a ≥4-point improvement in Edinburgh Postnatal Depression Scale (EPDS) score.
Let's personalize your content